Omni mini-LED sets feature a 4K QLED mini-LED display capable of delivering up to 1,400 nits of peak brightness, and support ...

The Valeda ® Light Delivery System (LumiThera, Inc.) is the first ever FDA-authorized treatment for vision loss in dry AMD, the manufacturer reported. The technology was evaluated in the LIGHTSITE III ...

We recently compiled a list of the 10 Best Metaverse Stocks To Buy According to Hedge Funds. In this article, we are going to ...

Ms. Connell is a commercial executive with business development expertiseAppointment takes place as Opthea prepares for Phase 3 wet AMD topline ...

MEDIA RELEASEAfqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One ...

Despite the introduction of therapies targeting VEGF, less than half of all treated patients with wet AMD, the most common ...

I am thrilled to further strengthen and enrich Ocular’s senior leadership team with the appointment of Namrata as Chief Business Officer. She brings a unique perspective to the role of CBO based on ...

The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular degeneration.

The FDA announced marketing authorization of a form of light therapy as the first-ever treatment for dry age-related macular ...

A new study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet age ...

AMD CIO Hasmukh Ranjan has the company on the path to take full advantage of advances in artificial intelligence.

Retinal thinning in patients with AMD is associated with thinner cortices in brain regions involved in vision and cognition.